EarCentric EasyCharge vs Otofonix Groove

The EarCentric EasyCharge is a budget-priced prescription hearing aid available for $229, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This behind-the-ear rechargeable device ranks #36 of 39 prescription hearing aids tested, placing it in the bottom tier of its category. In our standardized testing, the EasyCharge demonstrates a stark performance divide. Its standout strength is feedback handling, scoring an excellent 5.0/5—slightly above the category average of 4.72. This means users can expect stable performance without whistling during typical daily activities. However, speech clarity metrics tell a different story: speech in quiet scores just 1.0/5, which is 2.40 points below the category average, and speech in noise also scores 1.0/5, falling 1.11 points below average. Music streaming scored 0.0/5, indicating this device is not suitable for audio enjoyment. Own-voice comfort is also limited at 1.9/5, which is 0.80 points below the prescription hearing aid average of 2.70. The device showed no improvement between initial and tuned fitting conditions, with both scoring 2.7/5. At this price point, shoppers should note that alternatives exist with meaningfully better performance. The RxEars Rxi, available in the same price range, scores 4.07/5. The EasyCharge may appeal to those prioritizing feedback-free operation on a tight budget, but its low speech clarity scores suggest significant limitations for everyday conversation.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE ranks #38 of 39 devices in the prescription hearing aid category, placing it in the bottom 5% of its class. In our testing, the Groove demonstrated excellent feedback handling at 5.0/5, scoring 0.28 points above the category average. This represents a genuine strength, with the device maintaining stability during our standardized challenge motions. However, speech performance was significantly limited, with speech in quiet scoring 1.0/5 (2.40 points below the category average of 3.40) and speech in noise also at 1.0/5 (1.11 points below average). Music streaming was not functional in our tests, scoring 0.0/5 against a category average of 2.76. Own-voice comfort also fell well below typical prescription hearing aid performance at 0.4/5, which is 2.30 points below the category average. At this price point, several lower-cost alternatives delivered stronger overall performance in our testing. Consumers seeking value in the prescription category may want to explore other options, though those requiring robust feedback control in a rechargeable BTE format may find the Groove's stability noteworthy despite its other limitations.